Looking Good Sunpharma Financial Statements
These documents include SUN PHARMACEUTICALs income statement its balance sheet and the statement of cash flows.
Sunpharma financial statements. Financial statements are prepared under historical cost convention on an accrual basis in accordance with the Indian GAAP. Next SUN PHARMACEUTICAL earnings date is Aug 17 the estimation is 600. Sun Pharma Standalone March 2021 Net Sales at Rs 315964 crore up 1141 Y-o-Y 02022021 Sun Pharma Consolidated December 2020 Net Sales at Rs 883678 crore up 836 Y-o-Y.
Highlights of Q4FY21 consolidated financials Consolidated sales from operations at Rs. SUN PHARMACEUTICAL INDUSTRIES LTD. Sun Pharma Consolidated December 2020 Net Sales at Rs 883678 crore up 836 Y-o-Y.
The companys EPS TTM is 1208 dividend yield is 095 and PE is 5656. Annual Reports Presentations Sun Pharmaceutical Industries Limited. Reported amount of assets and liabilities on the date of the financial statements.
Sun Pharmaceutical Industries Ltd. Typically a companys financial statements are the reports that show the financial position of the company. Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterlysemi-annual financial statements published by the company for 5 interims history.
Financial summary of SUN PHARMACEUTICAL with all the key numbers The current SUNPHARMA market cap is 1645T. NCLT does not impact the consolidated financial statements of the Company. Sun Pharmaceuticals Industries Ltd balance sheet Financials Capital market.
524715 reported financials for the fourth quarter full year ending March 31st 2021. 26709 million growth of. Sun Pharma Standalone March 2021 Net Sales at Rs 315964 crore up 1141 Y-o-Y.